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Several studies have indicated that inflammation during pregnancy increases the risk
for the development of neuropsychiatric disorders in the offspring. Morphological brain
abnormalities combined with deviations in the inflammatory status of the brain can be
observed in patients of both autism and schizophrenia. It was shown that acute infection
can induce changes in maternal cytokine levels which in turn are suggested to affect
fetal brain development and increase the risk on the development of neuropsychiatric
disorders in the offspring. Animal models of maternal immune activation reproduce the
etiology of neurodevelopmental disorders such as schizophrenia and autism. In this
study the poly (I:C) model was used to mimic viral immune activation in pregnant mice in
order to assess the activation status of fetal microglia in these developmental disorders.
Because microglia are the resident immune cells of the brain they were expected to be
activated due to the inflammatory stimulus. Microglial cell density and activation level in
the fetal cortex and hippocampus were determined. Despite the presence of a systemic
inflammation in the pregnant mice, there was no significant difference in fetal microglial
cell density or immunohistochemically determined activation level between the control
and inflammation group. These data indicate that activation of the fetal microglial cells
is not likely to be responsible for the inflammation induced deficits in the offspring in this
model.
Keywords: neuropsychiatric disorders, maternal immune activation, microglia, embryo, cortex
Introduction
Schizophrenia and autism are neurodevelopmental disorders that can arise early during postnatal
life. Although genetic deﬁcits are important risk factors, perturbations of local environment,
especially during pregnancy, are suspected to play a central role in the occurrence of
these neurodevelopmental disorders. Maternal immune activation (MIA) during pregnancy is
considered as a risk factor for schizophrenia and autism in the oﬀspring (Brown, 2012). To study
the mechanisms behind this association several animal models were developed in which pregnant
rodents were infected with the inﬂuenza virus, polyinosinic:polycytidylic acid [poly (I:C)] or
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lipopolysaccharide (LPS) (Patterson, 2009). These models
conﬁrmed that prenatal infection leading to MIA can lead to
behavioral and neurological disorders in the oﬀspring (Shi et al.,
2003; Meyer et al., 2006; Fortier et al., 2007; Lowe et al., 2008;
Harvey and Boksa, 2012; Giovanoli et al., 2013; Squarzoni et al.,
2014). During MIA evoked by poly (I:C), an elevated maternal
serum cytokine, interleukin-6 (IL-6), was found to be critical for
the development of these neurological deﬁcits in the oﬀspring
(Samuelsson et al., 2006; Smith et al., 2007). Diﬀerences in
behavioral abnormalities observed in the oﬀspring at adult age are
critically dependent on the time of maternal poly (I:C) challenge,
being related to diﬀerences in cytokine responses in the fetal brain
shortly after the induction of MIA (Meyer et al., 2006, 2008).
However, the source of the cytokine response in the fetal brain
remains a matter of debate as it can originate from maternal,
placental and/or embryonic tissue. An endogenous increase in
fetal brain cytokine production was demonstrated using mRNA
analysis of the cytokine expression level upon maternal poly (I:C)
challenge during the late gestation stage in mice (17 embryonic
days, E17; Meyer et al., 2006). This was not observed when
maternal poly (I:C) challenge was performed at mid gestation
stage (E9; Meyer et al., 2006), a developmental age at which
immature microglia, the resident immune cells of the brain, have
not yet invaded the fetal central nervous system (CNS; Ginhoux
et al., 2010; Rigato et al., 2011; Swinnen et al., 2013).
Microglia colonize the brain early during embryonic
development (E11.5 in the mouse embryo; Ginhoux et al., 2010;
Rigato et al., 2011; Swinnen et al., 2013) and are known to
control several developmental processes in the brain at perinatal
developmental stages (Cunningham et al., 2013; Squarzoni et al.,
2014; Michell-Robinson et al., 2015). First, embryonic microglia
have been shown to be involved in angiogenesis through close
contact with vessel sprouts and endothelial tip cells and the
secretion of soluble factors that stimulate angiogenesis during
development (Fantin et al., 2010; Rymo et al., 2011). Secondly,
during CNS development microglial cells clear cellular debris
and induce programmed cell death in developing neurons via
the production of superoxide ions (Marin-Teva et al., 2004;
Wakselman et al., 2008) and tumor necrosis factor (TNF)-α
(Sedel et al., 2004). Thirdly, several studies have pointed toward
an important role for microglia in synaptic remodeling and
synapse elimination (Tremblay et al., 2010; Paolicelli et al.,
2011; Schafer et al., 2012; Zhan et al., 2014). Finally, microglial
cells can also inﬂuence the development and diﬀerentiation
of neural cells. Microglia-conditioned media can inﬂuence
embryonic precursor migration and diﬀerentiation in primary
cultures (Aarum et al., 2003; Jonakait et al., 2011). In addition,
microglial cells can regulate cortical precursor proliferation
and astrogenesis (Nakanishi et al., 2007). Primary culture
experiments on embryonic precursor cultures showed that
microglial cells are important for precursor proliferation and
astrogenesis. In microglia-depleted cultures and cultures from
PU.1 knock out embryos proliferation and astrogenesis were
decreased. Addition of microglia to these cultures restored
both processes and an abnormal increase in microglial cell
numbers resulted in increased astrogenesis (Antony et al.,
2011). Deactivation of embryonic microglia with tetracyclines
or elimination via the macrophages suicide technique led to an
increase in neural precursor cells, while microglial activation had
the opposite eﬀect (Cunningham et al., 2013).
Maternal immune activation induces an imbalance in
cytokines levels, of which maternal IL-6 has been shown to
be a critical mediator in inducing the eﬀects of MIA on
brain development and behavioral changes (Smith et al., 2007).
IL-6 is known to induce activation of adult microglial cells;
leading to the production of pro-inﬂammatory factors, such as
nitric oxide, reactive oxygen species, proteolytic enzymes, and
TNF-α by microglial cell cultures (Krady et al., 2008), microglial
proliferation (in vitro; Streit et al., 2000) and inﬁltration
(in vivo; Lacroix et al., 2002) or the upregulation of microglial
CX3CR1, making them more sensitive to fractalkine signaling
(Lee et al., 2010). An imbalance in cytokine levels caused
by MIA might thus be able to activate embryonic microglia,
even at early developmental stages, and alter their normal
functions. This can trigger a cascade of events that could
lead to developmental defects observed in the oﬀspring of
LPS or poly (I:C) treated pregnant mice. Indeed, MIA evoked
by LPS injection evoked microglia activation and enhanced
phagocytosis of neural precursors by microglia at prenatal
stages in rats (Cunningham et al., 2013). However, the question
remains whether an endogenous increase in fetal brain cytokine
production in response to maternal poly (I:C) challenge is
of microglial origin. Accordingly it remains unclear whether
poly (I:C)-induced MIA results in the activation of embryonic
microglia during fetal development.
To determine to what extent MIA evoked by poly (I:C) can
alter cortex invasion by microglia and/or change embryonic
microglial cell activation state, we evoked MIA using a single
(at E11.5) or a double injection (at E11.5 and E15.5) of poly
(I:C) (Meyer et al., 2006; Shi et al., 2009). This developmental
time window is an important time point for cortex invasion by
immature microglia as their cell density dramatically increases
during this period (Swinnen et al., 2013). We show that
poly (I:C)-induced MIA does not aﬀect microglial density and
activation level during embryonic development suggesting that
pathological activation of embryonic microglial cells at the
onset of their colonization processes cannot explain neurological
deﬁcits observed at postnatal stages in oﬀspring after poly (I:C)-
induced MIA.
Materials and Methods
Animals
All experiments were conducted in accordance with the
European Community guiding principles on the care and use
of animals and with the approval of the Ethical Committee on
Animal Research of Hasselt University. Mice were maintained in
the animal facility of the Hasselt University in accordance with
the guidelines of the Belgian Law and the European Council
Directive. To visualize microglia in the embryonic cortex the
transgenic CX3CR1-eGFP knock-in mice (Jung et al., 2000) were
used. The heterozygous CX3CR1-eGFP embryos used in this
study were obtained by crossing wild type C57BL/6 females with
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homozygous CX3CR1-eGFP +/+ male mice (obtained from the
European Mouse Mutant Archive – EMMA with the approval
of Jung et al., 2000). The day of conception was designated as
embryonic day 0.5 (E0.5).
Maternal Immune Activation
At day E11.5 (single injection) or at E11.5 and E15.5 (double
injection) mice received i.p. a dose of poly (I:C) (20 mg/kg;
Polyinosinic–polycytidylic acid potassium salt; Sigma–Aldrich,
Bornem, Belgium) or vehicle (saline). Five hours after injection
the maternal blood was collected, the serum was aliquoted and
stored at −80◦C until the IL-6 assay was performed (Shi et al.,
2003; Smith et al., 2007). The maternal IL-6 concentrations
were determined using the Mouse IL-6 ELISA Kit from Thermo
Scientiﬁc (Rockford, IL, USA), following the manufacturer’s
instructions. The analysis was conducted using a FLUOstar
OPTIMA plate reader (BMG Labtech, Ortenberg, Germany).
Fluorescent Immunostaining of Embryonic
Brains
Pregnant mice were sacriﬁced and embryonic tissue processed
as described before (Swinnen et al., 2013). The heads of E11.5
and E12.5 embryos were ﬁxed in 4% paraformaldehyde for 3 h
at 4◦C and 5 h for E17.5 embryos. After ﬁxation, the embryonic
heads were cryoprotected overnight in phosphate-buﬀered saline
(PBS) + 30% sucrose, frozen in optimal cutting temperature
compound (Tissue-Tek) and stored at −80◦C until sectioned.
Ten micrometer-thick coronal tissue sections were cut on a Leica
CM1900 uv cryostat, mounted on Superfrost Plus glasses and
stored at −20◦C until staining.
To check whether embryonic microglia can be directly
activated by poly (I:C), IL-6 or LPS, 300-μm thick coronal brain
slices (E15.5) were cultured for 24 h with either saline, poly
(I:C) (50 μg/ml), IL-6 (10 ng/ml), or LPS (1 μg/ml). To this
end, pregnant mothers were euthanized at E15.5. Embryonic
brains were isolated in ice-cold PBS-glucose (pH 7.4; 25 mM),
embedded in 3% low melting agarose (Fisher Scientiﬁc) and
sliced coronally at a thickness of 300 μm using a Microm
HM650V Vibrating Blade Microtome. Slices were mounted on
MilliCell organotypic inserts (Millipore) and maintained in semi-
hydrous conditions at 37◦C and 5% CO2 for 24 h. The media
consisted of Neurobasal medium supplemented with 2 mM L-
glutamine, B27 supplement, N2 supplement, and 0.5% penicillin–
streptomycin (all from Invitrogen) with either saline, poly (I:C)
(50 μg/ml), IL-6 (10 ng/ml) or LPS (1 μg/ml) added. Afterward
slices were ﬁxed for 1 h in 4% PFA and cryoprotected overnight
in PBS + 30% sucrose, frozen in optimal cutting temperature
compound (Tissue-Tek) and stored at −80◦C until sectioned.
Ten micrometer-thick coronal tissue sections were cut on a Leica
CM1900 uv cryostat, mounted on Superfrost Plus glasses and
stored at −20◦C until staining.
In order to determine the activation state of the microglia,
we used antibodies against interleukin (IL)-1β, inducible nitric
oxide synthase (iNOS) and Mac-2/Galectin-3 (Rigato et al., 2011;
Cunningham et al., 2013). All primary antibodies and working
solutions are listed in Table 1.
TABLE 1 | Overview of the antibodies used for immunostainings and flow
cytometry experiments.
Antibody Company Reference Dilution
Immunohistochemistry
Anti-IL1β (rabbit
polycl.)
Abcam ab9722 1:100
Anti-iNOS (rabbit
polycl.)
Abcam ab15323 1:250
Anti-Mac-2 (rat
monocl.)
American type
culture collection
TIB-166 1:250
Flow cytometry
Anti-IL1β PE (rat
monocl.)
LifeSpan
BioSciences
LS-C184791 1:300
Anti-iNOS PE-Cy7
(rat monocl.)
eBioscience 25-5920 1:300
Anti-Mac-2 PE (rat
monocl.)
eBioscience 12-5301 1:300
Isolation of Microglia and Flow Cytometry
Experiments
Brains were isolated from CX3CR1-eGFP E17.5 embryos from
mothers subjected to a single saline or poly (I:C) injection on
E11.5, or a double poly (I:C) injection on E11.5 and E15.5.
All steps occurred at 4◦C or on ice, unless stated otherwise,
to avoid microglia activation. Meninges were removed, the
cortical area identical to the immunohistochemical analysis
was dissected out and incubated during 30 min at 30◦C in
DMEM/F-12(1:1) + GlutaMAX (Life Technologies) containing
48 U/ml Papain from papaya latex (Sigma). Papain containing
supernatants was discarded and the tissue was mechanically
disrupted in medium through fast pipetting using a 1 ml pipet.
Afterward, the homogenate was centrifuged at 400g during
5 min, resuspended in 40% isotonic Percoll (GE Healthcare)
and centrifuged at 700g during 10 min without break. The
pellet was resuspended in PBS and ﬁltered through a 35 μm
cell strainer. Cell suspensions were ﬁxed and permeablized
in Cytoﬁx/Cytoperm buﬀer (BD Cytoﬁx/CytopermTM Plus
Fixation/Permeabilization Kit, BD Biosciences) during 20 min
on ice, washed and incubated on ice for 30 min in Perm/Wash
buﬀer with a mix of ﬂuorochrome-conjugated rat anti-mouse
antibodies: iNOS-PE-Cy7 (clone CXNFT, eBioscience), Mac-2-
PE (clone eBioM3/38, eBioscience) and, IL1β-PE (clone 11n92,
LifeSpan BioSciences) (Table 1). The following isotype controls
were used: Rat IgG2aκ PE-Cy7, Rat IgG2aκ PE and Rat
IgG2b PE (all from eBioscience). After washes, cells were
resuspended in FACS buﬀer (PBS, 2% FCS, sodium azide),
acquired in a FACS Aria II and analyzed with FACS Diva
6.1.3 software (BD Biosciences). Isotype-marker overlay graphs
were created in FlowJo 10.0.8 Software. Inside the singlet
population, the eGFP positive microglia (1000–12000 cells per
experiment) were gated (Figure 5A), and within this population,
the percentage of Mac-2, iNOS, and IL1β positive microglia
was analyzed. Isotype controls were used to gate the positive
cell population (Figure 5B). Per group, embryos were derived
from one to three diﬀerent mothers (saline, single poly (I:C),
double poly(I:C)). BV-2 cells (Supplementary Data) were used
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as positive controls for the diﬀerent antibodies (Supplementary
Figure S1).
Analysis and Statistics
Quantitative analysis of microglial cells was performed on images
of coronal embryonic brain sections. We focused our analysis on
the cerebral cortex area located dorsally to the lateral ganglionic
eminences (LGE) and medial ganglionic eminences (MGE),
containing the frontal and pariental cortex on E11.5 and E12.5,
and the somatosensory and motor cortex at E17.5. This region
of the cortex is well characterized on the functional and cellular
level and the two GE structures are the major sources of cortical
interneurons during embryonic neurogenesis (Tan et al., 1998;
Anderson et al., 2001). For the quantiﬁcations of the hippocampal
area at E17.5 only the dorsal hippocampus was included in the
analysis.
Images were taken with a Nikon Eclipse 80i microscope
and a Nikon digital sight camera DS-2MBWc [10x Nikon plan
objective (numerical aperture (NA) of 0.25) and a 20x Plan Fluor
objective (NA of 0.5)]. Images (1600 × 1200) were analyzed
with ImageJ 1.45e software (NIH, USA; http://rsb.info.nih.gov/
ij/). Only eGFP-positive cell bodies were taken into account for
the measurements. Density analysis was performed by counting
the number of eGFP positive cell bodies per mm2 (Swinnen
et al., 2013). For analysis of activation state we calculated the
percentage of the eGFP positive cells that were also showing
immunoreactivity for the activation marker. All values are
expressed as mean ± SEM. The number of sections used is
indicated as n, the number of embryos or blood samples as
N; # sections/# embryos is thus designated in the text as n/N.
Statistical signiﬁcance was assessed by non-parametric Mann–
Whitney test or Kruskal–Wallis test, P-values smaller than 0.05
were considered signiﬁcant.
Results
An increase in IL-6 level in the maternal blood is a crucial
factor in the development of MIA-induced deﬁcits and changes
observed in the oﬀspring (Smith et al., 2007). To control that the
poly (I:C) injection procedure we used evoked an increase in IL-
6 level in the maternal blood, we analyzed the IL-6 level in the
maternal serum samples 5 hours after injection of either saline or
poly (I:C). We found a signiﬁcant increase (P < 0.0001; Mann–
Whitney test) in the level of IL-6 in the sera of femalemice primed
with poly (I:C) (1876 ± 389.2 pg/ml, N = 22) when compared
to those injected with saline (14.8 ± 3.3 pg/ml, N = 26), thus
indicating that themice in the poly (I:C) group eﬀectively suﬀered
from a systemic immune response.
In response to brain injury, microglia proliferate and shift
to beneﬁcial or detrimental activation states depending on the
local environment. When activated, microglial cells adopt a
phagocytic phenotype in order to clear dying cells (Kettenmann
et al., 2011). In pathological conditions, such as in the mouse
model of LPS-induced MIA, phagocytosis of neuronal precursor
cells by microglia was also increased, which resulted in a
decrease in the size of the precursor cell pool in the cerebral
cortex (Cunningham et al., 2013). It must also be noted that
microglial disturbances were also observed in patients suﬀering
from autistic or schizophrenic disorders. Microglial activation
has been observed in the brains of autistic (Vargas et al., 2005;
Morgan et al., 2010) and schizophrenic patients (Radewicz
et al., 2000; Wierzba-Bobrowicz et al., 2005; Monji et al.,
2013). Recent studies also indicated that there is an increase
in microglial density in diﬀerent brain regions in the adult
poly (I:C) MIA oﬀspring (Juckel et al., 2011; Ratnayake et al.,
2012).
To determine if poly (I:C)-evoked MIA alters the embryonic
microglial cell colonization process in the fetal brain we
compared cell density after single injection of poly (I:C), double
injection of poly (I:C) or saline treatments, in the cortex at
E11.5, E12.5 and at E17.5 (single injection) or at E17.5 (double
injections) and in the hippocampal area at E17.5 (single and
double injections). At all ages tested we did not ﬁnd any
signiﬁcant diﬀerence in microglia cell density (Mann–Whitney
test; P > 0.05, for detailed P-values see Table 2) in the cortex
or in the hippocampus after a single or after double injections
(Figure 1; Table 2), thus suggesting that poly (I:C)-evoked MIA
does not alter early invasion of the cortex and the hippocampus
by microglial cells in the embryo.
To determine if MIA induced a change inmicroglial activation
level after a single poly (I:C) injection (E11.5), we performed
an immunostaining for three diﬀerent activation markers: Mac-
2/Galectin-3, iNOS and IL1β at E11.5 and E17.5.Mac-2/Galectin-
3 is a marker of microglial phagocytic activation state (Dumic
et al., 2006; Rotshenker, 2009) while iNOS and IL1β are
markers of a cytotoxic activation state (Cunningham et al.,
2013). At E11.5 none of the microglia located in the cortex was
immmunopositive for Mac-2 staining both after saline injection
TABLE 2 | Microglial cell density in the cortex and hippocampal area of
embryos derived from the control group and the group that was subjected
to maternal inflammation at E11.5 or at E11.5 and E15.5.
Brain structure Cortex Hippocampus
Embryonic age E11.5 E12.5 E17.5 E17.5
Single injection at E11.5
Saline 48.6 ± 8.8 34.9 ± 2.8 59.6 ± 5.8 122.5 ± 4.9
Poly (I:C) 32.2 ± 5.7 37.8 ± 2.9 56.5 ± 4.3 111.6 ± 5.7
P value 0.191 0.375 0.573 0.435
Brain structure Cortex Hippocampus
Embryonic age E17.5 E17.5
Double injection at E11.5 and E15.5
Saline 59.8 ± 3.1 95.3 ± 4.8
Poly (I:C) 57.8 ± 2.2 91.0 ± 5.7
P value 0.931 0.699
Values are mean ± SEM of the number of microglial cells per mm2, Mann–Whitney
test was used for statistical analysis. When injected at E11.5 the numbers of
embryonic brains in the saline and poly (I:C) group were, respectively: E11.5 = 4/5;
E12.5 = 12/7; E17.5 cortex = 6/8; E17.5 hippocampus = 5/8. When injected at
E11.5 and E15.5 numbers of embryonic brains in the saline and poly (I:C) group
were, respectively: E17.5 cortex = 5/6; E17.5 hippocampus = 6/6.
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FIGURE 1 | Embryonic microglial cell density is not increased after
single and double injection of poly (I:C). Microglial cell density in the cortex
and hippocampal area was not affected after poly (I:C)-induced MIA. Values
are mean ± SEM of the number of microglial cells per mm2, Mann–Whitney
test was used for statistical analysis. When injected at E11.5 the numbers of
embryonic brains in the saline and poly (I:C) group were, respectively:
E11.5 = 4/5; E12.5 = 12/7; E17.5 cortex = 6/8; E17.5 hippocampus = 5/8.
When injected at E11.5 and E15.5 numbers of embryonic brains in the saline
and poly (I:C) group were, respectively: E17.5 cortex = 5/6; E17.5
hippocampus = 6/6. c, cortex; h, hippocampal area; D, double injection.
(n/N = 14/3) and after poly (I:C) challenge (n/N = 18/3;
Figure 2B1,B2). At E17.5, 2.5 ± 0.5% (n/N = 38/4) of the
microglia in the cortex (Figure 2A1,A2) and 3.2 ± 0.7%
(n/N = 27/4) of the microglia in the hippocampal area
expressed Mac-2 after saline injection. We did not ﬁnd any
signiﬁcant diﬀerence (Kruskal–Wallis test; P = 0.448) after
poly (I:C) challenge. After poly (I:C) challenge, 1.9 ± 0.7%
(n/N = 23/4) of the microglia in the cortex and 2.5 ± 1%
(n/N = 15/4) of microglia in hippocampal area expressed Mac-
2 (Figures 2C1,C2,D1,D2). We next investigated the expression
of IL1β and iNOS (Cunningham et al., 2013) to determine
if embryonic microglia can adopt a cytotoxic activation state
after a single injection of poly (I:C). Induction of MIA by a
single injection of poly (I:C) did not result in a signiﬁcant
increase in the percentage of microglia expressing IL1β either
at E11.5 and E17.5 (Kruskal–Wallis test; P = 0.136). In control
conditions, 0 ± 0% (n/N = 6/3) and 2.2 ± 1% (n/N = 15/4)
of microglia located in the cortex expressed IL1β at E11.5
and E17.5 (Figure 3A1,A2), respectively, while 3.1 ± 1.3%
(n/N = 17/4) expressed IL1β in the hippocampal area (E17.5).
After poly (I:C) challenge, 3.3 ± 3.3% (n/N = 10/3) and 3.5 ± 1%
(n/N = 19/4) of microglia located in the cortex expressed
IL1β at E11.5 (Figure 3B1,B2) and at E17.5 (Figure 3C1,C2),
respectively, while 7.2 ± 2.6% (n/N = 17/4) expressed IL1β
in the hippocampal area (E17.5; Figure 3D1,D2). We found
similar results when analyzing iNOS expression at E11.5 and
E17.5 in the cortex and in the hippocampal area (E17.5). Cortical
iNOS expression in control conditions [E11.5: 8.3 ± 5.7%,
n/N = 10/3; E17.5: 2.0 ± 1.1%, n/N = 15/4 (Figure 4A1,A2)]
was not signiﬁcantly diﬀerent when compared to the poly (I:C)
condition [E11.5: 0 ± 0%, n/N = 8/3 (Figure 4B1,B2); E17.5:
1.9 ± 1.1%, n/N = 12/4 (Figure 4C1,C2; Kruskal–Wallis test;
P = 0.471)]. In the hippocampal area, 1.5 ± 1.0% of microglia
(n/N = 14/4) express iNOS in control conditions while 0 ± 0%,
of microglia (n/N = 10/4) express iNOS after poly (I:C) challenge
(Figure 4D1,D2, being not signiﬁcantly diﬀerent (Kruskal–
Wallis test; P = 0.471)).
This lack of change in embryonic microglia activation
state after a single poly (I:C) injection could possibly lead
only to a “primed” microglial state. Indeed, two injections of
LPS were necessary in rat to elicit MIA induced microglia
dysfunction during phagocytosis of cortical neural precursor
cells (Cunningham et al., 2013), suggesting that the microglial
phenotype could become only fully altered after the second
inﬂammatory challenge. To determine if this is also the case
for poly (I:C) we reanalyzed microglial density and activation
level after a repeated injection of poly (I:C). Consequently, the
mothers suﬀered from a double immune stimulation (on E11.5
as well as on E15.5). Despite the presence of a maternal immune
response after both injections, there was no signiﬁcant increase
in microglial cell density (Mann–Whitney test; P > 0.05, for
detailed P-values see Table 2) (Figure 1; Table 2). Microglial
activation states were analyzed at E17.5 as described above.
We did not ﬁnd any signiﬁcant diﬀerence (Kruskal–Wallis test;
Mac-2, P = 0.139; IL1β, P = 0.945; iNOS, P = 0.093) in the
percentage of microglia expressingMac-2, IL1β, or iNOS between
control conditions and after double injections of poly (I:C).
After double injections of poly (I:C) the percentage of microglia
immunoreactive for Mac-2 antibody was 0 ± 0% (n/N = 29/6) in
the cortex (Figure 2E1,E2) and 2.0 ± 0.7% (n/N = 22/6) in the
hippocampal area (Figure 2F1,F2). In the cortex (Figure 3E1,E2)
and hippocampal area (Figure 3F1,F2) 1.4 ± 0.7% (n/N = 34/6)
and 1.4 ± 1.0% (n/N = 25/6) of the microglial cells showed
immunoreactivity for the IL1β antibody, while 1.8 ± 0.7%
(n/N = 34/6) and 0 ± 0% (n/N = 23/6) of the microglia were
positive for iNOS in the cortex (Figure 4E1,E2) and hippocampal
area (Figure 4F1,F2), respectively. These results indicate that
even double injections of poly (I:C) did not evoke microglia
activation in the embryo.
In addition to the immunohistochemical stainings, the
presence of the activation markers on microglial cells at E17.5
was investigated by ﬂow cytometry. The gating strategy and
positive controls are shown in Figures 5A,B and Supplementary
Figure S1. The results of the ﬂow cytometric quantiﬁcations were
similar to those obtained by immunohistochemistry. There was
no signiﬁcant diﬀerence in the proportion of microglial cells
that were positive for Mac-2 after single poly (I:C) injection
(16.8± 0.0%; N= 10) or double poly (I:C) injection (27.0± 4.6%;
N = 10) when compared to the control group (15.5 ± 4.3; N = 5;
Figure 5C, left; Kruskal–Wallis test, P = 0.161). The proportion
of microglial cells that were positive for IL1β in the control group
(14.2 ± 3.1%; N = 10) was not signiﬁcantly diﬀerent (Figure 5C,
middle; Kruskal–Wallis test, P = 0.093) to the percentage of
microglia that was positive for IL1β after a single (22.3 ± 3.9%;
N = 8) or double poly (I:C) injection (16.0 ± 2.1%; N = 6). The
percentage of microglial cells positive for iNOS in the control
group was 9.1 ± 2.8% (N = 5). There was no signiﬁcant eﬀect
(Figure 5C, right; Kruskal–Wallis test, P = 0.816) of a single
poly (I:C) (7.1 ± 1.5%; N = 10) or double poly (I:C) challenge
(9.9 ± 2.7%; N = 10) on the percentage of microglia expressing
this marker.
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FIGURE 2 | Embryonic microglial cell population is poorly
immunoreactive to the Mac-2/Galectin-3 antibody after single and
double injection of poly (I:C). (A–F1) Coronal sections of embryonic
brains, with cell nucleus staining in blue (DAPI) and microglial
(CX3CR1-eGFP) cells in green. Immunohistochemical staining using a
Mac-2 antibody (red) showed that at E17.5 almost no microglial cells in
the cortex were immunoreactive for Mac-2 (A2) after injection with saline.
At E11.5 (B2) and E17.5 (C2,E2) in the cortex and E17.5 hippocampal
area (D2,F2) there was no increased percentage of microglial cells
expressing the activation marker after poly (I:C) challenge compared to
control. White square indicates the location of the cells in the tissue
showed in the inset; ∗ indicates a Mac-2 positive eGFP cell. Examples of
one control brain area and poly (I:C) group only as they were not
significantly different. Scale bar = 100 μm and for insets = 20 μm.
The absence of activation marker expression by microglia after
poly (I:C) challenge raised the question whether fetal microglia
can be directly activated by a poly (I:C) challenge as suspected for
LPS (Cunningham et al., 2013) and IL-6 (Smith et al., 2007). To
address this issue we analyzed the activation state of microglia
in acute embryonic brain slices (E15.5) after exposure to IL-6,
poly (I:C) or LPS. The percentage of microglial cells expressing
Mac-2/Galectin-3, iNOS, and IL1β were analyzed 24 h after
immune challenge of the slices (Figure 6D). Figure 6 insets show
examples of microglial cells that did (Figures 6A–C2) or did
not show immunoreactivity (Figures 6A–C3) for the activation
markers tested (Mac-2, IL1β, and iNOS). In control conditions
31 ± 5.9%, (n/N = 23/4) of microglia were immunoreactive
for Mac-2 antibody. This percentage was signiﬁcantly higher
(Kruskal–Wallis test; P < 0.0001) than that observed in vivo
indicating that an in vitro environment promotes microglia
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FIGURE 3 | Embryonic microglia show no increased expression of IL1β
after single and double injection of poly (I:C). (A–F1) Coronal sections of
embryonic brains, with cell nucleus staining in blue (DAPI) and microglial
(CX3CR1-eGFP) cells in green. Immunohistochemical staining using an IL1β
antibody (red) showed that at E17.5 almost no microglial cells in the cortex were
immunoreactive for IL1β (A2) after injection with saline. At E11.5 (B2) and E17.5
(C2,E2) in the cortex and E17.5 hippocampal area (D2,F2) there was no
increased percentage of microglial cells expressing the activation marker after
poly (I:C) challenge compared to control. White square indicates the location of
the cells in the tissue showed in the inset; ∗ indicates an IL1β positive eGFP cell.
Examples of one control brain area and poly (I:C) group only as they were not
significantly different. Scale bar = 100 μm and for insets = 20 μm.
phagocytic activation state. However, there was no signiﬁcant
eﬀect (Kruskal–Wallis test; P = 0.274) of IL-6, poly (I:C) or LPS
treatment on the percentage of microglia being immunoreactive
to Mac-2 antibody (Figure 6D), being 34 ± 5.5% (n/N = 22/4)
after IL-6 exposure, 32 ± 6.7%, (n/N = 18/5) after poly (I:C)
exposure and 47 ± 7.5% (n/N = 21/5) after LPS exposure
(Figure 6D). As observed for Mac-2, the percentage of IL1β
immunoreactive microglia was signiﬁcantly higher than in in vivo
conditions [in control conditions 52 ± 6.8%, (n/N = 27/4;
Kruskal–Wallis test; P < 0.0001)] and for iNOS a trend to a
higher percentage was observed under control conditions [in
control conditions 18 ± 5.7%, (n/N = 23/4; Kruskal–Wallis test;
P = 0.091)]. As shown in Figure 6D treatment with IL-6 or poly
(I:C) did not signiﬁcantly change the percentage of microglia
immunoreactive for IL1β or iNOS antibodies. When looking at
IL1β immunoreactivity, 36 ± 7.2% (n/N = 16/4) of the microglia
was positive after IL-6 exposure and 54 ± 7.5%, (n/N = 19/5)
after poly (I:C) exposure (Figure 6D). For iNOS they were
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FIGURE 4 | Embryonic microglia cell population is poorly
immunoreactive to the iNOS antibody after single and double
injection of poly (I:C). (A–F1) Coronal sections of embryonic brains,
with cell nucleus staining in blue (DAPI) and microglial
(CX3CR1-eGFP) cells in green. Immunohistochemical staining using an
iNOS antibody (red) showed that at E17.5 almost no microglial cells
in the cortex were immunoreactive for iNOS (A2) after injection with
saline. At E11.5 (B2) and E17.5 (C2,E2) in the cortex and E17.5
hippocampal area (D2,F2) there was no increased percentage of
microglial cells expressing the activation marker after poly (I:C)
challenge compared to control. White square indicates the location of
the cells in the tissue showed in the inset. Examples of one control
brain area and poly (I:C) group only as they were not significantly
different. Scale bar = 100 μm and for insets = 20 μm.
30 ± 6.5% (n/N = 19/4) after IL-6 exposure and 25 ± 3.9%,
(n/N = 25/5) after poly (I:C) exposure (Figure 6D). However,
we found that LPS, contrary to IL-6 or poly (I:C), can directly
activate microglia to a detrimental activation state. Indeed LPS
exposure signiﬁcantly increased the percentage of microglia
immunoreactive for IL1β (Kruskal–Wallis test; P = 0.025) or
iNOS antibodies (Kruskal–Wallis test; P= 0.025). In the presence
of LPS 66 ± 5.5 (n/N = 22/5) and 42 ± 7.1% (n/N = 21/5)
of microglia were immunoreactive for IL1β antibody or iNOS
antibody, respectively.
Discussion
Maternal immune activation-induced behavioral and
neurological alterations observed in the oﬀspring at juvenile and
adult stages in animals are supposed to be correlated with the
etiology of neuropsychiatric disorders in humans. Our study
in mice demonstrates, for the ﬁrst time, that MIA evoked by
single or double poly (I:C) injections does not change microglia
density and their activation state in the embryo in vivo. This
suggests that the behavioral and neurological alterations in the
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FIGURE 5 | Flow cytometry reveals that embryonic microglial cells
show a poor expression of activation markers Mac-2, IL1β and
iNOS. (A) Gating strategies for the microglial cells. In the whole
embryonic cortex cell suspension, a gate was created on the non-debris
population (left). Inside this population, single cells were selected (middle)
and within this population, the microglial cells were gated based on
CX3CR1-eGFP intensity (right). SSC, Side scatter; FSC, Forward scatter.
(B) Gating strategies for positive Mac-2, iNOS and IL1β populations.
Microglial cell count of representative samples is shown for Mac-2 (left),
IL1β (middle) and iNOS (right; full lines) for embryos derived from saline,
single poly (I:C) and double poly (I:C) injected mothers. Gates for
positive populations were drawn based on the isotype fluorescence
intensity (dotted lines). FI, fluorescence intensity. (C) Left panels: at
E17.5 only a small percentage of microglial cells shows reactivity for
Mac-2. There is no significant effect of poly (I:C) injection on this
percentage. Number of embryos tested: Saline N = 5; single poly (I:C)
N = 10 and double poly (I:C) N = 10. Middle panels: in control
conditions, less than 15% of the microglial cells is positive for IL1β.
There is no significant effect of poly (I:C) injection on this proportion.
Number of embryos tested: Saline N = 10; single poly (I:C) N = 8
and double poly (I:C) N = 6. Right panels: at E17.5 less than 10% of
the microglial cells is positive for iNOS. Poly (I:C) challenge has no
significant effect on this percentage. Number of embryos tested: saline
N = 5; single poly (I:C) N = 10 and double poly (I:C) N = 10.
Frontiers in Cellular Neuroscience | www.frontiersin.org 9 August 2015 | Volume 9 | Article 301
Smolders et al. Immune activation and embryonic microglia
FIGURE 6 | Microglial activation in acute brain slices. Example of
activation marker stainings on acute slices treated with LPS.
(A) Immunohistochemical staining for Mac-2/Galectin-3 (red), nuclei were
visualized with DAPI (blue; A1). Microglia (green) positive (A1 white square, A2)
for Mac-2/Galectin-3 (red) and microglia that do not express the marker (white
triangle, A3) were present in the slice. (B) Immunohistochemical staining for
iNOS (red), nuclei were visualized with DAPI (blue; B1). Microglial cells that were
positive (white square B1,B2) and negative (white triangle B1,B3) for iNOS (red)
were observed in the slice after LPS treatment. (C) Immunohistochemical
staining for IL1β (red), nuclei were visualized with DAPI (blue; C1). Microglial cells
that were positive (white square C1,C2) and negative (white triangle C1,C3) for
IL1β (red) were observed in the slice after LPS treatment. Examples of the
different immunostainings were taken from slices treated for 24 h with 1 μg/ml
LPS. Scale bar = 50 μm and for inserts = 20 μm. White squares indicate the
microglia positive for the marker and shown in higher magnification (A–C2),
white triangles indicate microglia negative for the marker and shown in higher
magnification (A–C3). (D) Quantification of the expression of three activation
markers (Mac-2, iNOS, and IL1β) by microglia in E15.5 brain slices cultured for
24 h with IL-6 (10 ng/ml), poly (I:C) (50 μg/ml), or LPS (1 μg/ml). Kruskal–Wallis
test was used for statistical analysis. Number of treated slices in control and IL-6
group N = 4; LPS and poly (I:C) group N = 5. Number of cryosections for
Mac-2/iNOS/IL1β in: saline group n = 23/23/27; IL-6 group n = 22/19/16; poly
(I:C) group n = 18/25/19; LPS group n = 21/21/22 (all derived from three
different embryos). (∗p < 0.05).
oﬀspring cannot be related to the alteration of the activation
state of embryonic microglial cells. Our in vitro studies indicated
that microglia cannot be directly activated by poly (I:C) or
IL-6 exposure, contrary to the activation observed upon LPS
application.
Several observations suggest that the diﬀerent infectious
triggers induce diﬀerences in activation of embryonic microglia.
The cytokine IL-6 can cross the placenta barrier in vivo
when maternal inﬂammation was induced during mid-gestation
(Kohmura et al., 2000; Ashdown et al., 2006; Dahlgren et al.,
2006), but it is not clear whether poly (I:C) as well can cross
the placenta (Brown and Patterson, 2011). LPS is shown to cross
the placenta barrier in vivo when maternal inﬂammation was
induced during early gestation (Cai et al., 2000; Kohmura et al.,
2000), but this was not the case when LPS was injected at late
gestation (Ashdown et al., 2006). Although extrapolation of these
results to a poly (I:C) challenge would suggest that embryonic
microglia are directly or indirectly activated in response to
poly (I:C)-induced MIA at mid gestation, we could not ﬁnd
any evidence for microglia activation in this study. Previously,
microglia dysfunction observed after poly (I:C)-induced MIA
was only reported in oﬀspring at postnatal and adult age (Juckel
et al., 2011; Manitz et al., 2012). In that way it is of interest
to compare in parallel the eﬀect of MIA induced by diﬀerent
infectious agents on the embryonic microglia. Studies using
single or repeated LPS challenge showed that this leads to
microglial activation: in the fetal sheep brain, microglial cell
numbers increased as well as the number of activated/amoeboid
cells (Mallard et al., 2003; Hutton et al., 2008; Kuypers et al.,
2013); in the rat embryo the percentage of microglia expressing
iNOS and IL1β was increased (Cunningham et al., 2013) and
postnatally a changed immunoreactivity by microglial cells was
still observed (Cai et al., 2000); and in mice Iba-1 reactivity was
increased during late embryonic and early postnatal stages (Le
Belle et al., 2014). In conclusion, the time of injection and the
nature of the infectious trigger determine whether an activation
of the embryonic microglia does or does not participate to
developmental neurological defects observed in MIA oﬀspring
(Garay et al., 2012). In addition the microglial response might
be species dependent. However, a thorough comparison of the
eﬀect of MIA in diﬀerent species is diﬃcult to make for several
reasons. For example, some studies use the mRNA and/or protein
expression level of diﬀerent cytokines as read-out (Garay et al.,
2012) while others use immunohistochemistry (Cunningham
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et al., 2013; Giovanoli et al., 2013) or cell number (Hutton et al.,
2008; Manitz et al., 2012) to investigate microglial cell activation
after MIA. In addition, the eﬀect of MIA is studied on several
diﬀerent postnatal and adult time points.
Microglial activation in postnatal to adult brains has been
found to correlate to neurodevelopmental diseases. An active
neuroinﬂammatory process, with microglial cell activation, was
described in the brains of autistic patients (Vargas et al., 2005;
Morgan et al., 2010) and of schizophrenic patients (Radewicz
et al., 2000; Wierzba-Bobrowicz et al., 2005; Monji et al., 2013).
However, it remains unclear if microglia activation participates
to neuronal disorders or reﬂects a normal microglia response to
neural dysfunctions. Our results show that poly (I:C)-induced
MIA does not lead to activation of embryonic microglia. Yet,
they cannot exclude that the embryonic microglial cells become
primed, which could result in a more vigorous response to
a subsequent inﬂammatory stimulation in the adult. In some
neurodegenerative disease models in rodents (for example
Alzheimer’s, Parkinson’s, and prion disease) the injection of
LPS or poly (I:C) leads to a more severe pathology. The
combined exposure of a prenatal immune challenge [poly (I:C)
at E9] and peripubertal stress (from P30 to 40) resulted in
the development of sensorimotor gating deﬁciencies and led to
increased dopamine levels in the adult hippocampus (Giovanoli
et al., 2013). At peripubertal age, the combination of both
stressors resulted in altered neuroimmune responses, presented
as increased microglial cell number and elevated levels of IL1β
and TNFα in the hippocampus and prefrontal cortex (Giovanoli
et al., 2013). These latter changes were transient, as they were
not longer present in the adult. Finally, low doses of poly
(I:C) worsened the deﬁcits in pre-pulse inhibition and latent
inhibition in 16 week-old mice with mutations in a schizophrenia
susceptibility gene but had no eﬀect in wild-type animals, thus
indicating that genetic and environmental factors can interact
to worsen the schizophrenia-related behavior (Lipina et al.,
2013).
MIA induces not only a cytokine response in the maternal
unit but also alters several cytokine levels in the placenta and in
the fetus (Patterson et al., 2008; Pratt et al., 2013). Under normal
conditions cytokines are present in the placental unit where they
play an important role in controlling the tissue homeostasis and
balance of the diﬀerent T-cell types present in this structure.
In addition, toll-like receptors (TLR), such as TLR-2 and 4, are
expressed on human chorionic villi (Jonakait, 2007). Maternal
injection with IL-6 is known lead to endocrine changes in the
placenta (Hsiao and Patterson, 2011) and injection of a high dose
of LPS results in placental inﬂammation (Girard et al., 2010) and
induction of pro-inﬂammatory cytokines in the amniotic ﬂuid
(Gayle et al., 2004). In addition, a direct injection of LPS into the
uteroplacental circulation leads to a reaction in the embryonic
brain, suggesting the placental unit can contribute to perinatal
brain damage through the induction of an inﬂammatory reaction
as a response to infection during pregnancy (Hutton et al., 2008).
This complicates elucidating the site where the cytokines act
upon to potentially alter brain development since they can act
directly on neural progenitors and neurons (Bauer et al., 2007;
Deverman and Patterson, 2009). For example, IL-6 and LIF can
inﬂuence the diﬀerentiation of neural progenitor cells (Nakanishi
et al., 2007).
These data, in combination with the lack of microglial
activation in our MIA study suggests that the acute maternal
inﬂammation induced by poly (I:C) could aﬀect other systems
or cell types during embryonic stages. These MIA-induced early
abnormalities might result in an altered CNS environment
in the oﬀspring that in turn aﬀects the microglial cells at
later developmental stages. This hypothesis is supported by
the observed changes in neurotransmitter systems in the adult
oﬀspring and not in the pre-pubertal period after challenge with
poly (I:C) (Manitz et al., 2012). GABAergic gene expression,
like GABA receptor subunits and vesicular transporters, can
be altered in the adult prefrontal cortex after MIA (Richetto
et al., 2013). In addition, serotonin and glutamate signaling
was altered (Holloway et al., 2013). These changes were not
present at pre-pubertal ages. It is also important to note that,
although microglia do not invade the CNS of mouse embryo
at E9 (Rigato et al., 2011; Swinnen et al., 2013), poly (I:C)
challenge at this gestation stage resulted in the suppression
of spatial exploration in the adult (Meyer et al., 2006). This
reinforces the idea that embryonic microglia dysfunction, if any,
is unlikely to be the main mechanism inducing developmental
disorders featuring pathological behavior. Accordingly, poly (I:C)
challenge at E9 did not evoke any increase in cytokine mRNA
level in the fetal brain (Meyer et al., 2006). Poly (I:C) might
induce developmental deﬁcits via direct action on neuronal
development. However, our results cannot exclude that poly
(I:C) evokes an embryonic microglia priming resulting in an
exaggerated response of microglia to homeostatic disturbances
at postnatal stages and subsequently makes neuronal dysfunction
worse.
Conclusion
Our ﬁndings show that a single and double injection of poly
(I:C) is not suﬃcient to induce changes in fetal microglia
activation phenotype during mid or late embryonic development.
In addition they suggest a diﬀerent response of the embryonic
brain to MIA depending on the challenge procedure used.
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